Role of the Microbiome, Probiotics, and ‘Dysbiosis Therapy’ in Critical Illness
Current Opinion in Critical Care - United States
doi 10.1097/mcc.0000000000000321
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2016
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)